Elevance Health ELV Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $9.66B+1.7% | $9.49B+8.9% | $8.71B+1.8% | $8.56B+14.1% | $7.5B-9.5% | ||
| $25.91B+0.1% | $25.88B-1.5% | $26.28B+3.9% | $25.3B-0.5% | $25.44B+0.9% | ||
| $11.53B+14.4% | $10.07B+5.6% | $9.54B-8.9% | $10.47B+1.0% | $10.36B+29.3% | ||
| $67.03B+6.4% | $63B-1.2% | $63.78B+0.7% | $63.32B+3.6% | $61.12B+3.7% | ||
| $4.66B-0.5% | $4.68B+0.5% | $4.66B+0.3% | $4.64B+0.5% | $4.62B-0.8% | ||
| $28.34B0.0% | $28.34B-0.4% | $28.45B+0.3% | $28.37B-0.2% | $28.42B+0.5% | ||
| $1.51B+104% | $740M-39.3% | $1.22B+30.6% | $934M+30.6% | $715M-40.0% | ||
| $125.83B+3.6% | $121.49B-1.0% | $122.75B+0.7% | $121.94B+1.9% | $119.72B+2.4% | ||
| $724M+383% | $150M-16.7% | $180M-50.0% | $360M+44.0% | $250M-31.5% | ||
| $724M+383% | $150M-16.7% | $180M-50.0% | $360M+44.0% | $250M-31.5% | ||
| $1.76B+17.8% | $1.49B-18.5% | $1.83B+17.3% | $1.56B-4.8% | $1.64B+8.8% | ||
| $45.31B+10.4% | $41.04B+0.4% | $40.88B-6.7% | $43.83B+2.7% | $42.7B+5.2% | ||
| $30.77B-0.1% | $30.8B-1.2% | $31.17B+10.6% | $28.18B+0.2% | $28.11B-3.8% | ||
| $3.92B+11.2% | $3.53B-14.8% | $4.14B+6.0% | $3.9B-2.3% | $3.99B+20.1% | ||
| $81.79B+5.6% | $77.47B-1.5% | $78.67B+0.7% | $78.09B+1.3% | $77.1B+2.2% | ||
| $8.85B-1.0% | $8.94B+0.3% | $8.91B-0.3% | $8.93B+0.7% | $8.87B-0.5% | ||
| $35.8B+1.1% | $35.39B-0.5% | $35.59B+0.1% | $35.55B+2.9% | $34.55B+3.0% | ||
| -$741M-64.3% | -$451M+16.9% | -$543M+28.6% | -$760M+16.6% | -$911M+20.6% | ||
| $43.9B0.0% | $43.88B-0.2% | $43.95B+0.5% | $43.72B+2.9% | $42.5B+2.9% | ||
| $125.83B+3.6% | $121.49B-1.0% | $122.75B+0.7% | $121.94B+1.9% | $119.72B+2.4% | ||
| $25.91B+0.1% | $25.88B-1.5% | $26.28B+3.9% | $25.3B-0.5% | $25.44B+0.9% | ||
| $7.17B+34.2% | $5.34B+2.5% | $5.21B-3.6% | $5.41B+2.3% | $5.29B+12.5% | ||
| $5.1B-1.2% | $5.16B+0.8% | $5.12B-6.1% | $5.45B+4.0% | $5.25B+4.0% | ||
| $1.11B-0.6% | $1.12B+0.9% | $1.11B+2.2% | $1.09B+2.5% | $1.06B+2.4% | ||
| $11.09B-1.0% | $11.2B-1.1% | $11.33B-1.4% | $11.49B-3.8% | $11.94B-1.3% | ||
| $2.58B+11.8% | $2.31B-16.8% | $2.78B+8.4% | $2.56B+7.1% | $2.39B+11.8% | ||
| $11.01B+1.6% | $10.84B+1.8% | $10.65B+1.7% | $10.47B+2.9% | $10.17B+4.3% | ||
| $11.01B+1.6% | $10.84B+1.8% | $10.65B+1.7% | $10.47B+2.9% | $10.17B+4.3% | ||
| $2.58B+11.8% | $2.31B-16.8% | $2.78B+8.4% | $2.56B+7.1% | $2.39B+11.8% | ||
| $6.21B-15.2% | $7.32B+20.3% | $6.09B-16.4% | $7.28B+2.1% | $7.13B+2.9% | ||
| $18.43B+7.8% | $17.08B-0.4% | $17.15B0.0% | $17.16B+2.0% | $16.81B+6.8% | ||
| $13.99B+36.4% | $10.26B-17.6% | $12.44B+1.2% | $12.29B+7.6% | $11.43B+13.9% | ||
| $3.86B+6.2% | $3.63B+48.4% | $2.45B-30.9% | $3.54B-6.7% | $3.8B-9.7% | ||
| $31.49B-0.4% | $31.61B+0.8% | $31.35B+9.9% | $28.54B+0.6% | $28.36B-6.7% | ||
| $2M0.0% | $2M0.0% | $2M0.0% | $2M0.0% | $2M0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $1.79B-15.4% | $2.11B-8.9% | $2.32B+15.3% | $2.01B-5.3% | $2.12B-1.3% | ||
| $140M-2.8% | $144M+11.6% | $129M0.0% | $129M+10.3% | $117M+5.4% | ||
| $6.17B-2.2% | $6.31B-18.0% | $7.69B+6.7% | $7.21B+9.6% | $6.58B+9.3% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Elevance Health's total assets?
- Elevance Health (ELV) holds $125.83B in total assets, up 5.1% year over year.
- How much debt does Elevance Health have?
- Elevance Health carries $31.5B in total debt against $43.9B of shareholders' equity, a debt-to-equity ratio of 0.72.
- How much cash does Elevance Health have?
- Elevance Health holds $9.7B in cash and equivalents.
- Can Elevance Health cover its short-term obligations?
- Its current ratio is 1.48 — current assets exceed current liabilities.
- Where does Elevance Health's balance sheet data come from?
- Every line is extracted from Elevance Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
